The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Biolase's Revenue for the
three
months ended in Dec. 2023 was $13.49 Mil. Biolase's average Accounts Receivable for the
three
months ended in Dec. 2023 was $4.94 Mil.
Hence, Biolase's Receivables Turnover for the
three
months ended in Dec. 2023 was 2.73.
Biolase Receivables Turnover Historical Data
The historical data trend for Biolase's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biolase's Receivables Turnover
For the Medical Devices subindustry, Biolase's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biolase's Receivables Turnover Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biolase's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Biolase's Receivables Turnover falls into.
Biolase Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
Biolase's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Biolase Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Biolase's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIOL has been successfully added to your 